Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancer

1 Aug 2004

Abstract excerpt

Peroxisome proliferator activated receptor-gamma (PPARgamma) belongs to a family of nuclear receptors and acts as a receptor for peroxisome proliferators, steroids, retinoic acids and polyunsaturated fatty acids. The current study examined both the transcript levels of PPARgamma and its coactivator PGC-1, and the localisation of these molecules in breast cancer tissues. Both PPARgamma and PGC-1 were located...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory mediators and NSAID effects
Share to Metabolism, Diabetes, and Cancer
Share to Peroxisome Proliferator-Activated Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15254719
DOI: 10.3892/or.12.2.483

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The localisation and reduction of nuclear staining of PPARγ and PGC-1 in human breast cancerPMID 15254719Read ↗

Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progressionSemantic proximity Read ↗

Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancersSemantic proximity Read ↗

Anticancer activities of PPARγ in breast cancer are context-dependent.Semantic proximity Read ↗

Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progressionSemantic proximity Read ↗

Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.Semantic proximity Read ↗

Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line.Semantic proximity Read ↗

The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.Semantic proximity Read ↗

Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer ChemopreventionSemantic proximity Read ↗

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells.Semantic proximity Read ↗

Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.Semantic proximity Read ↗

Down-regulation of PPARgamma1 suppresses cell growth and induces apoptosis in MCF-7 breast cancer cells.Semantic proximity Read ↗

Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.